crusader medical care ltd Company Information
Company Number
05010791
Next Accounts
Dec 2025
Shareholders
crusader medical care holdings limited
Group Structure
View All
Industry
Residential nursing care activities
Registered Address
chestnut house tawe business vil, swansea enterprise park, swansea, SA7 9LA
Website
www.crusadermedicalcare.comcrusader medical care ltd Estimated Valuation
Pomanda estimates the enterprise value of CRUSADER MEDICAL CARE LTD at £5.3m based on a Turnover of £6.3m and 0.83x industry multiple (adjusted for size and gross margin).
crusader medical care ltd Estimated Valuation
Pomanda estimates the enterprise value of CRUSADER MEDICAL CARE LTD at £5.9m based on an EBITDA of £840.1k and a 7.06x industry multiple (adjusted for size and gross margin).
crusader medical care ltd Estimated Valuation
Pomanda estimates the enterprise value of CRUSADER MEDICAL CARE LTD at £13.9m based on Net Assets of £5.1m and 2.75x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Crusader Medical Care Ltd Overview
Crusader Medical Care Ltd is a live company located in swansea, SA7 9LA with a Companies House number of 05010791. It operates in the residential nursing care facilities sector, SIC Code 87100. Founded in January 2004, it's largest shareholder is crusader medical care holdings limited with a 100% stake. Crusader Medical Care Ltd is a mature, mid sized company, Pomanda has estimated its turnover at £6.3m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Crusader Medical Care Ltd Health Check
Pomanda's financial health check has awarded Crusader Medical Care Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs


4 Strong

4 Regular

3 Weak

Size
annual sales of £6.3m, make it larger than the average company (£4.9m)
£6.3m - Crusader Medical Care Ltd
£4.9m - Industry AVG

Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (7.5%)
2% - Crusader Medical Care Ltd
7.5% - Industry AVG

Production
with a gross margin of 41%, this company has a comparable cost of product (36.2%)
41% - Crusader Medical Care Ltd
36.2% - Industry AVG

Profitability
an operating margin of 12.3% make it as profitable than the average company (14.2%)
12.3% - Crusader Medical Care Ltd
14.2% - Industry AVG

Employees
with 144 employees, this is above the industry average (116)
144 - Crusader Medical Care Ltd
116 - Industry AVG

Pay Structure
on an average salary of £24.5k, the company has an equivalent pay structure (£24.2k)
£24.5k - Crusader Medical Care Ltd
£24.2k - Industry AVG

Efficiency
resulting in sales per employee of £43.8k, this is equally as efficient (£42.3k)
£43.8k - Crusader Medical Care Ltd
£42.3k - Industry AVG

Debtor Days
it gets paid by customers after 3 days, this is earlier than average (18 days)
3 days - Crusader Medical Care Ltd
18 days - Industry AVG

Creditor Days
its suppliers are paid after 6 days, this is quicker than average (18 days)
6 days - Crusader Medical Care Ltd
18 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Crusader Medical Care Ltd
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (9 weeks)
6 weeks - Crusader Medical Care Ltd
9 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 36.6%, this is a lower level of debt than the average (56.8%)
36.6% - Crusader Medical Care Ltd
56.8% - Industry AVG
CRUSADER MEDICAL CARE LTD financials

Crusader Medical Care Ltd's latest turnover from March 2024 is £6.3 million and the company has net assets of £5.1 million. According to their latest financial statements, Crusader Medical Care Ltd has 144 employees and maintains cash reserves of £385 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Apr 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6,308,000 | 5,836,000 | 5,895,000 | 5,510,000 | 5,221,845 | 4,930,776 | 4,682,301 | 4,135,763 | 2,655,456 | 2,208,859 | |||||
Other Income Or Grants | 406,000 | 1,000 | |||||||||||||
Cost Of Sales | 3,724,000 | 3,455,000 | 3,211,000 | 2,849,000 | 2,803,099 | 2,599,794 | 2,418,849 | 2,123,672 | 1,408,546 | 1,190,925 | |||||
Gross Profit | 2,584,000 | 2,381,000 | 3,090,000 | 2,662,000 | 2,418,746 | 2,330,982 | 2,263,452 | 2,012,091 | 1,246,910 | 1,017,934 | |||||
Admin Expenses | 1,438,000 | 803,000 | 775,691 | 705,292 | 679,545 | 799,426 | 505,754 | 341,513 | |||||||
Operating Profit | 1,652,000 | 1,859,000 | 1,643,055 | 1,625,690 | 1,583,907 | 1,212,665 | 741,156 | 676,421 | |||||||
Interest Payable | 21,000 | 65,000 | 72,434 | 71,641 | 88,987 | 83,388 | 59,829 | 37,307 | |||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 616,000 | 553,000 | 1,631,000 | 1,794,000 | 1,570,621 | 1,554,049 | 1,494,920 | 1,129,277 | 681,327 | 639,114 | |||||
Tax | -6,000 | -120,000 | -241,000 | -383,000 | -311,008 | -308,853 | -309,422 | -222,329 | -161,023 | -115,607 | |||||
Profit After Tax | 610,000 | 433,000 | 1,390,000 | 1,411,000 | 1,259,613 | 1,245,196 | 1,185,498 | 906,948 | 520,304 | 523,507 | |||||
Dividends Paid | 4,301,000 | 410,000 | 363,075 | 339,896 | 334,963 | 286,440 | 293,500 | 157,159 | |||||||
Retained Profit | 610,000 | 433,000 | -2,911,000 | 1,001,000 | 896,538 | 905,300 | 850,535 | 620,508 | 226,804 | 366,348 | |||||
Employee Costs | 3,523,000 | 3,057,000 | 3,200,000 | 2,830,000 | 2,757,093 | 2,559,629 | 2,387,115 | 2,266,938 | 1,422,225 | 1,161,458 | |||||
Number Of Employees | 144 | 137 | 124 | 119 | 119 | 122 | 125 | 115 | 116 | 112 | 60 | ||||
EBITDA* | 1,828,000 | 2,016,000 | 1,804,668 | 1,807,171 | 1,747,370 | 1,363,733 | 817,230 | 736,902 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Apr 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 338,000 | 301,000 | 157,000 | 224,000 | 4,238,000 | 4,237,451 | 4,268,662 | 4,286,207 | 4,359,525 | 4,343,879 | 2,440,669 | 2,216,695 | 2,228,854 | 2,209,931 | 2,243,705 |
Intangible Assets | |||||||||||||||
Investments & Other | 1 | 1 | |||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 338,000 | 301,000 | 157,000 | 224,000 | 4,238,000 | 4,237,452 | 4,268,663 | 4,286,207 | 4,359,525 | 4,343,879 | 2,440,669 | 2,216,695 | 2,228,854 | 2,209,931 | 2,243,705 |
Stock & work in progress | 2,000 | 2,000 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | 2,200 | |||
Trade Debtors | 69,000 | 238,000 | 452,000 | 79,000 | 298,000 | 255,078 | 57,259 | 209,449 | 19,385 | 144,042 | 25,038 | 64,190 | 520 | 593 | 6,173 |
Group Debtors | 7,195,000 | 4,894,000 | 3,439,000 | 2,035,000 | |||||||||||
Misc Debtors | 11,000 | 7,000 | 275,000 | 585,000 | 1,268,000 | 1,248,333 | 1,371,224 | 598,008 | 204,405 | 139,160 | 83,218 | ||||
Cash | 385,000 | 997,000 | 733,000 | 755,000 | 3,008,000 | 2,272,886 | 1,928,129 | 1,727,515 | 1,481,589 | 900,067 | 989,849 | 511,858 | 288,437 | 215,305 | 142,360 |
misc current assets | |||||||||||||||
total current assets | 7,660,000 | 6,136,000 | 4,899,000 | 3,456,000 | 4,576,000 | 3,778,497 | 3,358,812 | 2,537,172 | 1,707,579 | 1,185,469 | 1,100,305 | 578,248 | 291,157 | 218,098 | 150,733 |
total assets | 7,998,000 | 6,437,000 | 5,056,000 | 3,680,000 | 8,814,000 | 8,015,949 | 7,627,475 | 6,823,379 | 6,067,104 | 5,529,348 | 3,540,974 | 2,794,943 | 2,520,011 | 2,428,029 | 2,394,438 |
Bank overdraft | |||||||||||||||
Bank loan | 305,000 | 270,000 | 270,000 | 270,000 | 227,000 | 90,000 | |||||||||
Trade Creditors | 67,000 | 161,000 | 71,000 | 24,000 | 32,000 | 28,631 | 16,164 | 14,750 | 14,579 | 18,751 | 36,855 | 234,253 | 587,154 | 631,798 | 714,178 |
Group/Directors Accounts | 1,946,000 | 805,000 | 65,000 | ||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 913,000 | 1,010,000 | 892,000 | 450,000 | 517,000 | 453,974 | 706,964 | 563,692 | 449,196 | 216,760 | 207,620 | ||||
total current liabilities | 2,926,000 | 1,976,000 | 1,028,000 | 474,000 | 854,000 | 752,605 | 993,128 | 848,442 | 690,775 | 325,511 | 244,475 | 234,253 | 587,154 | 631,798 | 714,178 |
loans | 1,671,000 | 2,010,768 | 2,281,053 | 2,523,153 | 2,770,579 | 3,210,519 | 1,660,082 | 1,300,519 | 680,000 | ||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 381,171 | 1,200,543 | 1,336,479 | ||||||||||||
provisions | 172,000 | 135,671 | 132,927 | 136,717 | 141,218 | 149,294 | 19,197 | 9,299 | 8,350 | 4,524 | 4,011 | ||||
total long term liabilities | 1,843,000 | 2,146,439 | 2,413,980 | 2,659,870 | 2,911,797 | 3,359,813 | 1,679,279 | 1,309,818 | 1,069,521 | 1,205,067 | 1,340,490 | ||||
total liabilities | 2,926,000 | 1,976,000 | 1,028,000 | 474,000 | 2,697,000 | 2,899,044 | 3,407,108 | 3,508,312 | 3,602,572 | 3,685,324 | 1,923,754 | 1,544,071 | 1,656,675 | 1,836,865 | 2,054,668 |
net assets | 5,072,000 | 4,461,000 | 4,028,000 | 3,206,000 | 6,117,000 | 5,116,905 | 4,220,367 | 3,315,067 | 2,464,532 | 1,844,024 | 1,617,220 | 1,250,872 | 863,336 | 591,164 | 339,770 |
total shareholders funds | 5,072,000 | 4,461,000 | 4,028,000 | 3,206,000 | 6,117,000 | 5,116,905 | 4,220,367 | 3,315,067 | 2,464,532 | 1,844,024 | 1,617,220 | 1,250,872 | 863,336 | 591,164 | 339,770 |
Mar 2024 | Mar 2023 | Mar 2022 | Apr 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,652,000 | 1,859,000 | 1,643,055 | 1,625,690 | 1,583,907 | 1,212,665 | 741,156 | 676,421 | |||||||
Depreciation | 63,000 | 84,000 | 57,000 | 176,000 | 157,000 | 161,613 | 181,481 | 163,463 | 151,068 | 76,074 | 60,481 | 60,705 | 61,979 | 58,519 | 54,397 |
Amortisation | |||||||||||||||
Tax | -6,000 | -120,000 | -241,000 | -383,000 | -311,008 | -308,853 | -309,422 | -222,329 | -161,023 | -115,607 | |||||
Stock | -2,000 | -200 | 2,200 | ||||||||||||
Debtors | 2,136,000 | 973,000 | 1,467,000 | 1,133,000 | 62,589 | 74,928 | 621,026 | 583,667 | -59,412 | 174,946 | 44,066 | 63,670 | -73 | -5,580 | 6,173 |
Creditors | -94,000 | 90,000 | 47,000 | -8,000 | 3,369 | 12,467 | 1,414 | 171 | -4,172 | -18,104 | -197,398 | -352,901 | -44,644 | -82,380 | 714,178 |
Accruals and Deferred Income | -97,000 | 118,000 | 442,000 | -67,000 | 63,026 | -252,990 | 143,272 | 114,496 | 232,436 | 9,140 | 207,620 | ||||
Deferred Taxes & Provisions | -172,000 | 36,329 | 2,744 | -3,790 | -4,501 | -8,076 | 130,097 | 9,898 | 949 | 3,826 | 513 | 4,011 | |||
Cash flow from operations | 207,000 | 1,673,335 | 1,180,953 | 1,018,188 | 964,447 | 1,421,004 | 602,394 | 597,349 | |||||||
Investing Activities | |||||||||||||||
capital expenditure | -163,937 | -90,145 | -166,714 | -1,979,284 | -254,977 | ||||||||||
Change in Investments | -1 | 1 | |||||||||||||
cash flow from investments | 1 | -163,938 | -90,145 | -166,714 | -1,979,284 | -254,977 | |||||||||
Financing Activities | |||||||||||||||
Bank loans | -305,000 | 35,000 | 43,000 | 137,000 | 90,000 | ||||||||||
Group/Directors Accounts | 1,141,000 | 740,000 | 65,000 | ||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -1,671,000 | -339,768 | -270,285 | -242,100 | -247,426 | -439,940 | 1,550,437 | 359,563 | 620,519 | 680,000 | |||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -381,171 | -819,372 | -135,936 | 1,336,479 | |||||||||||
share issue | |||||||||||||||
interest | -21,000 | -65,000 | -72,434 | -71,641 | -88,987 | -83,388 | -59,829 | -37,307 | |||||||
cash flow from financing | 1,142,000 | 740,000 | -1,997,000 | -370,673 | -342,719 | -313,741 | -293,413 | -386,328 | 1,580,608 | 322,256 | |||||
cash and cash equivalents | |||||||||||||||
cash | -612,000 | 264,000 | -22,000 | -2,253,000 | 735,114 | 344,757 | 200,614 | 245,926 | 581,522 | -89,782 | 477,991 | 223,421 | 73,132 | 72,945 | 142,360 |
overdraft | |||||||||||||||
change in cash | -612,000 | 264,000 | -22,000 | -2,253,000 | 735,114 | 344,757 | 200,614 | 245,926 | 581,522 | -89,782 | 477,991 | 223,421 | 73,132 | 72,945 | 142,360 |
crusader medical care ltd Credit Report and Business Information
Crusader Medical Care Ltd Competitor Analysis

Perform a competitor analysis for crusader medical care ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SA7 area or any other competitors across 12 key performance metrics.
crusader medical care ltd Ownership
CRUSADER MEDICAL CARE LTD group structure
Crusader Medical Care Ltd has no subsidiary companies.
Ultimate parent company
SPECIALIST HEALTHCARE OPERATIONS LTD
#0117040
2 parents
CRUSADER MEDICAL CARE LTD
05010791
crusader medical care ltd directors
Crusader Medical Care Ltd currently has 7 directors. The longest serving directors include Mr Matthew Reade (Jun 2021) and Mr Matthew Reade (Jun 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Matthew Reade | United Kingdom | 55 years | Jun 2021 | - | Director |
Mr Matthew Reade | United Kingdom | 55 years | Jun 2021 | - | Director |
Mr Timothy Davies | United Kingdom | 51 years | Aug 2021 | - | Director |
Mr Timothy Davies | United Kingdom | 51 years | Aug 2021 | - | Director |
Mr Timothy Davies | United Kingdom | 51 years | Aug 2021 | - | Director |
Mr Neil Robinson | Wales | 42 years | Jun 2023 | - | Director |
Mr Erik Svensson | Wales | 57 years | Oct 2024 | - | Director |
P&L
March 2024turnover
6.3m
+8%
operating profit
777.1k
0%
gross margin
41%
+0.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
5.1m
+0.14%
total assets
8m
+0.24%
cash
385k
-0.61%
net assets
Total assets minus all liabilities
crusader medical care ltd company details
company number
05010791
Type
Private limited with Share Capital
industry
87100 - Residential nursing care activities
incorporation date
January 2004
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
st albans care home ltd (May 2014)
accountant
-
auditor
HAZLEWOODS LLP
address
chestnut house tawe business vil, swansea enterprise park, swansea, SA7 9LA
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
crusader medical care ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to crusader medical care ltd. Currently there are 1 open charges and 6 have been satisfied in the past.
crusader medical care ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CRUSADER MEDICAL CARE LTD. This can take several minutes, an email will notify you when this has completed.
crusader medical care ltd Companies House Filings - See Documents
date | description | view/download |
---|